Skip to main content

Financial news

The newsroom

Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.

Public RSS feeds · refreshed every 30 minutes

  • SEC EDGAR•filings
    8-K - Cartesian Therapeutics, Inc. (0001453687) (Filer)

    Cartesian Therapeutics filed a Form 8-K on September 29, 2026, containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Invivyd, Inc. (0001832038) (Filer)

    Invivyd, Inc. filed a Form 8-K on September 29, 2026 (Accession No. 0001193125-26-406007), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.

  • SEC EDGAR•filings
    8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer)

    Aquestive Therapeutics filed a Form 8-K on September 29, 2026, reporting director/officer changes and related compensation arrangements, and including its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - JELD-WEN Holding, Inc. (0001674335) (Filer)

    JELD-WEN Holding, Inc. filed a Form 8-K on September 29, 2026, disclosing a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer)

    Iovance Biotherapeutics, Inc. filed a Form 8-K on September 29, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - SHERWIN WILLIAMS CO (0000089800) (Filer)

    Sherwin-Williams filed an 8-K reporting entry into and termination of material definitive agreements, creation of a direct financial obligation, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - 1 800 FLOWERS COM INC (0001084869) (Filer)

    1-800 Flowers filed a Form 8-K on September 29, 2026, reporting entry into a material definitive agreement, providing a Regulation FD disclosure, and including financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Altimmune, Inc. (0001326190) (Filer)

    Altimmune, Inc. filed a Form 8-K reporting the departure of certain directors or officers, the election or appointment of new directors or officers, and disclosed compensatory arrangements for those officers.

  • SEC EDGAR•filings
    8-K - BeyondSpring Inc. (0001677940) (Filer)

    BeyondSpring Inc. filed a Form 8-K on September 29, 2026, reporting entry into a material definitive agreement, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Aldeyra Therapeutics, Inc. (0001341235) (Filer)

    Aldeyra Therapeutics, Inc. filed an 8-K with the SEC on September 29, 2026 (Accession No. 0001193125-26-405954), including a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - CID Holdco, Inc. (0002033770) (Filer)

    CID Holdco, Inc. filed a Form 8-K on September 29, 2026, reporting entry into a material definitive agreement and including its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - CARMAX INC (0001170010) (Filer)

    CarMax Inc. filed an 8-K on September 29, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Immix Biopharma, Inc. (0001873835) (Filer)

    Immix Biopharma, Inc. filed a Form 8-K on September 29, 2026, containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Atlantic Union Bankshares Corp (0000883948) (Filer)

    Atlantic Union Bankshares Corp filed a Form 8-K on September 29, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - T1 Energy Inc. (0001992243) (Filer)

    T1 Energy Inc. filed an 8-K reporting entry into a material definitive agreement, creation of a direct financial obligation or off-balance-sheet arrangement, unregistered sales of equity securities, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Alzamend Neuro, Inc. (0001677077) (Filer)

    Alzamend Neuro, Inc. filed a Form 8-K with the SEC on September 29, 2026, including a Regulation FD disclosure and financial statements with related exhibits.

  • SEC EDGAR•filings
    8-K - WESTLAKE CORP (0001262823) (Filer)

    Westlake Corp filed a Form 8-K reporting costs associated with exit or disposal activities and including a Regulation FD disclosure.

  • SEC EDGAR•filings
    8-K - LIBERTY STAR URANIUM & METALS CORP. (0001172178) (Filer)

    Liberty Star Uranium & Metals Corp filed a Form 8-K reporting entry into a material definitive agreement, creation of a direct financial obligation or off-balance-sheet arrangement, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Stewards, Inc. (0001795851) (Filer)

    Stewards, Inc. filed a Form 8-K on September 29, 2026 reporting a material definitive agreement, completion of an acquisition, creation of a direct financial obligation, unregistered equity sales, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - URANIUM ENERGY CORP (0001334933) (Filer)

    Uranium Energy Corp filed a Form 8-K on September 29, 2026, containing Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits.

  • ECB•monetary
    ECB amends monetary policy implementation guidelines as part of regular review

    The European Central Bank has revised its monetary policy implementation guidelines as part of its regular review process.

  • SEC EDGAR•filings
    8-K - TurnOnGreen, Inc. (0001349706) (Filer)

    TurnOnGreen, Inc. filed a Form 8-K on September 29, 2026 reporting amendments to its articles of incorporation or bylaws, a change in fiscal year, and the inclusion of financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Summit Therapeutics Inc. (0001599298) (Filer)

    Summit Therapeutics Inc. filed an 8-K reporting a material definitive agreement, unregistered equity sales, amendments to its articles of incorporation and bylaws including a fiscal year change, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - VerifyMe, Inc. (0001104038) (Filer)

    VerifyMe, Inc. filed a Form 8-K on September 29, 2026 (Accession No. 0001214659-26-012120), including Item 9.01 financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Futurewave Acquisition Corp (0002116105) (Filer)

    Futurewave Acquisition Corp filed a Form 8-K on September 29, 2026, disclosing entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - KORN FERRY (0000056679) (Filer)

    Korn Ferry filed an 8-K on September 29, 2026, reporting director and officer departures, appointments, compensatory arrangements, shareholder voting matters, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - AAR CORP (0000001750) (Filer)

    AAR Corp filed a Form 8-K on September 29, 2026 reporting entry into a material definitive agreement, unregistered equity sales, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Quantum-Si Inc (0001816431) (Filer)

    Quantum-Si Inc filed a Form 8-K with the SEC on September 29, 2026, containing a Regulation FD disclosure and accompanying financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - NEWS CORP (0001564708) (Filer)

    News Corp filed a Form 8-K on September 29, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - NETSOL TECHNOLOGIES INC (0001039280) (Filer)

    Netsol Technologies Inc. filed a Form 8-K on September 29, 2026, disclosing its results of operations and financial condition for the reporting period.